• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, August 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Untargeted metabolomics for atherosclerotic cardiovascular diseases

Bioengineer by Bioengineer
January 18, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This article by Dr. Vi T. Dang, Aric Huang and Dr. Geoff H. Werstuck is published in Cardiovascular & Hematological Disorders-Drug Targets, Volume 18 , Issue 3 , 2018

IMAGE

Credit: Geoff H. Werstuck, Bentham Science Publishers


CVD (cardiovascular diseases) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke. Regardless of many new treatments and measures took and still are taken place; in order to prevent cardiovascular diseases the number does not cease to decrease (the number of deaths). Therefore, new and even better therapies and treatments should be brought in the light for the betterment of those who are suffering from CVD. Metabolomics has offered a good solution for these diseases. Metabolomic-based biomarkers indicate the disease, as they are keen enough to detect it. At the same time, they are able enough to detect the risk of development of that disease and detect the disease before it comes to the surface.

In this study, analytical techniques are discussed along with the workflow that used in untargeted metabolomics. While case studies are also identified that were highlighting the use of untargeted metabolomics in CVD research. Out of all those, five of the case studies show approaches to identify the approach taken by untargeted metabolomics. These were taken for cardiovascular diseases and risks, myocardial ischemia, transient ischemic attack, incident coronary heart disease, and myocardial infarction risk. Prediction of all these were described. If we talk about cardiovascular research, the use of the untargeted metabolomics is still relatively new. Although, there is still a need for future advancements in metabolomics technologies.

Early diagnosis of CVD is a good sign for patient’s recovery and also for their health. Therefore, there is a need to establish sensitive and at the same time non-invasive biomarkers and also reliable therapeutic targets for prevention and treatment of CVD.

###

The article is open access till 31st January 2018. To obtain the article, please visit: http://www.eurekaselect.com/161468/article

Media Contact
Faizan ul Haq
[email protected]

Related Journal Article

http://dx.doi.org/10.2174/1871529X18666180420170108

Tags: CardiologyHematologyInternal MedicineMedicine/HealthPharmaceutical Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Unraveling EMT’s Role in Colorectal Cancer Spread

August 2, 2025
Gut γδ T17 Cells Drive Brain Inflammation via STING

Gut γδ T17 Cells Drive Brain Inflammation via STING

August 2, 2025

Agent-Based Framework for Assessing Environmental Exposures

August 2, 2025

MARCO Drives Myeloid Suppressor Cell Differentiation, Immunity

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    39 shares
    Share 16 Tweet 10
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Unraveling EMT’s Role in Colorectal Cancer Spread

Gut γδ T17 Cells Drive Brain Inflammation via STING

Agent-Based Framework for Assessing Environmental Exposures

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.